+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vaginal Rejuvenation Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896690
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Vaginal Rejuvenation Market is projected to reach USD 4.69 Billion in 2026. It is expected to continue growing at a CAGR of 9.29%, reaching USD 8.01 Billion by 2032.

The vaginal rejuvenation market is moving from a narrowly cosmetic category into a broader women’s health and feminine wellness segment that includes nonsurgical vaginal rejuvenation, energy-based vaginal therapies, pelvic floor support, and treatments positioned around genitourinary syndrome of menopause, vaginal laxity, sexual wellness, postpartum recovery, and quality-of-life concerns.

Demand is supported by aging demographics, rising awareness of menopause care, increased acceptance of minimally invasive aesthetic procedures, and greater patient willingness to discuss intimate health. At the same time, the market is highly evidence-sensitive: U.S. FDA safety communications and professional society guidance, including from obstetrics and gynecology groups, emphasize that promotional claims must be aligned with clinical evidence, regulatory clearance, informed consent, and patient safety.

Transformative Shifts in the Vaginal Rejuvenation Landscape

The competitive landscape is shifting toward clinically supervised, nonsurgical modalities such as fractional CO2 laser, erbium laser, radiofrequency vaginal rejuvenation, hybrid platforms, and adjunctive pelvic floor technologies. Providers are also integrating menopause counseling, sexual health assessment, and postpartum recovery support to move beyond one-time procedures into longitudinal care pathways.

A major transformation is the separation of evidence-based medical positioning from broad “rejuvenation” marketing. Clinics and device developers that document patient selection, informed consent, adverse event monitoring, clinician training, and validated outcome measures are better positioned than competitors relying on unverified aesthetic claims.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing patient education, appointment conversion, treatment planning, and post-procedure monitoring in the vaginal rejuvenation market. AI-enabled digital intake tools can help identify symptoms, contraindications, menopause status, prior childbirth history, medication use, and treatment expectations before clinician consultation, improving workflow efficiency and documentation.

The cumulative impact is strongest where AI supports, rather than replaces, licensed clinical judgment. Predictive analytics, image-assisted documentation, personalized follow-up, and adverse-event surveillance can improve quality assurance, but AI tools used in diagnosis or treatment recommendations must be assessed under applicable medical software, cybersecurity, consent, and privacy regulations.

Key Regional Insights

North America remains a leading region for vaginal rejuvenation due to high procedure awareness, established medical aesthetics infrastructure, broad access to gynecology and dermatology-led services, and strong demand for nonsurgical vaginal rejuvenation in the United States and Canada. Europe shows steady adoption through gynecology-led practices and aesthetics clinics, although claims scrutiny and medical device regulation encourage evidence-based positioning, particularly across European Union markets where clinical evaluation, post-market surveillance, and data protection requirements shape commercialization.

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and major Southeast Asian healthcare hubs combine rising disposable income, medical aesthetics acceptance, private specialty care, and growing focus on postpartum and menopause-related intimate wellness. Latin America, led by Brazil and Mexico, benefits from a mature cosmetic procedure culture, demand for minimally invasive procedures, and regional medical tourism. The Middle East shows demand through private healthcare, premium wellness clinics, and discreet women’s health services, particularly in urban Gulf markets. Africa is earlier-stage, with opportunities concentrated in urban private care settings where women’s health infrastructure, specialist access, and medical aesthetics awareness are improving.

Key Group Insights

Within ASEAN, growth is supported by medical tourism, expanding private hospitals, and rising acceptance of aesthetic gynecology in markets such as Thailand, Singapore, Malaysia, Indonesia, the Philippines, and Vietnam, where private-sector women’s health services increasingly combine wellness, aesthetics, and postpartum care. The GCC shows strong potential through high-spending private healthcare systems, premium wellness centers, and demand for discreet women’s health services, with adoption shaped by clinician availability, cultural sensitivity, and regulatory requirements for medical devices and healthcare advertising.

The European Union is shaped by tighter regulatory oversight, medical device compliance, clinical evaluation expectations, and post-market vigilance requirements, favoring well-documented technologies and conservative claims. BRICS markets offer scale through large patient populations, expanding middle classes, urban private healthcare, and rising awareness of menopause and intimate wellness, although access and regulatory maturity vary. G7 countries remain important for innovation, clinical research, premium device adoption, and professional training, while NATO markets overlap significantly with advanced healthcare systems where data protection, physician credentialing, patient safety, and regulatory discipline are central to commercialization.

Key Country Insights

The United States is the most influential country environment due to large medical aesthetics demand, high consumer awareness, and active regulatory oversight that has specifically addressed unsupported claims for energy-based vaginal procedures. Canada follows with cautious, clinician-led adoption and strong attention to patient safety. Mexico and Brazil benefit from strong cosmetic medicine cultures, private aesthetic clinics, and regional medical tourism, while the United Kingdom, Germany, France, Italy, and Spain show demand through gynecology, dermatology, urology, and aesthetics clinics, with compliance expectations shaped by European medical device standards, professional guidance, and health data protection. Russia maintains private-sector demand, but geopolitical, import, reimbursement, and access complexity can affect technology availability and commercial execution.

China and India provide long-term scale as women’s health awareness, urban private healthcare, and aesthetic medicine expand, though adoption depends on local regulatory pathways, clinician training, affordability, and culturally appropriate patient education. Japan emphasizes safety, precision, and conservative clinical adoption, while South Korea is influenced by its advanced aesthetics ecosystem, technology orientation, and medical tourism capabilities. Australia combines high healthcare standards with growing menopause and intimate wellness awareness, supporting measured adoption of vaginal laser therapy, radiofrequency platforms, pelvic floor technologies, and related services in compliant clinical settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical validation, transparent labeling, and responsible content that distinguishes between cosmetic wellness claims and medically indicated treatments. Marketing should avoid overstating outcomes and should align with regulatory clearances, professional guidance, peer-reviewed evidence, and documented clinical endpoints.

Commercial teams should invest in physician training, standardized consent protocols, contraindication screening, patient-reported outcome tracking, and adverse-event reporting. Partnerships with gynecologists, urogynecologists, menopause specialists, pelvic floor therapists, and evidence-focused aesthetic clinics can improve credibility while supporting sustainable growth in the vaginal rejuvenation market.

Research Methodology

This executive summary is developed from secondary research across regulatory communications, professional medical guidance, clinical literature, demographic indicators, and public information on medical aesthetics and women’s health trends. Sources considered include government health agencies, medical device oversight bodies, peer-reviewed publications, and recognized clinical societies.

The analysis applies triangulation across demand drivers, technology adoption, regional healthcare infrastructure, patient behavior, professional practice patterns, and regulatory risk. Insights are synthesized qualitatively to support strategic decision-making without using market estimation, market sizing, market share, forecasting, or unsupported clinical outcome claims.

Conclusion

Vaginal rejuvenation is entering a more disciplined growth phase where demand remains strong, but market success depends on safety, evidence, and clinician-led care. The most resilient participants will be those that combine minimally invasive technologies with responsible patient education, appropriate patient selection, and robust compliance.

As AI, digital health, and personalized women’s wellness converge, the market will continue to evolve beyond aesthetics alone. Organizations that invest in clinical credibility, regional adaptation, physician training, and ethical communications are positioned to capture durable opportunities in nonsurgical vaginal rejuvenation and intimate health services.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Vaginal Rejuvenation Market, by Treatment Type
7.1. Introduction
7.2. Biological
7.2.1. Platelet Rich Plasma
7.2.2. Stem Cell Therapy
7.3. Energy Based
7.3.1. High Intensity Focused Ultrasound
7.3.2. Intense Pulsed Light
7.3.3. Laser
7.3.4. Radiofrequency
7.4. Surgical
7.4.1. Hymenoplasty
7.4.2. Labiaplasty
7.4.3. Vaginoplasty
8. Vaginal Rejuvenation Market, by Hormonal Status
8.1. Introduction
8.2. Premenopausal
8.3. Perimenopausal
8.4. Postmenopausal
9. Vaginal Rejuvenation Market, by Age Group
9.1. Introduction
9.2. 18 To 34
9.3. 35 To 44
9.4. 45 To 54
9.5. 55 And Above
10. Vaginal Rejuvenation Market, by Application
10.1. Introduction
10.2. Combined Rejuvenation
10.3. External Rejuvenation
10.4. Internal Rejuvenation
11. Vaginal Rejuvenation Market, by End User
11.1. Introduction
11.2. Aesthetic Centers
11.3. Hospitals
11.4. Spa & Wellness Centers
11.5. Specialty Clinics
12. Vaginal Rejuvenation Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Vaginal Rejuvenation Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Vaginal Rejuvenation Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alma Lasers Ltd.
16.2. Asclepion Laser Technologies GmbH
16.3. BTL Industries Ltd.
16.4. Candela Corporation
16.5. Cutera Inc.
16.6. Cynosure Inc.
16.7. DEKA M.E.L.A. S.r.l.
16.8. Eunsung Global Corp.
16.9. Fotona d.o.o.
16.10. Hironic Co., Ltd.
16.11. Hologic Inc.
16.12. InMode Ltd.
16.13. Jeisys Medical Inc.
16.14. Lasering S.r.l.
16.15. Lumenis Ltd.
16.16. Lutronic Corporation
16.17. MedArt Inc.
16.18. Sciton Inc.
16.19. Syneron Candela Corporation
16.20. ThermiGen LLC
16.21. Venus Concept Group, Inc.
16.22. Viveve Medical Inc.
16.23. Wontech Co., Ltd.
16.24. Zimmer MedizinSysteme GmbH
List of Figures
FIGURE 1. GLOBAL VAGINAL REJUVENATION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VAGINAL REJUVENATION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VAGINAL REJUVENATION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VAGINAL REJUVENATION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VAGINAL REJUVENATION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VAGINAL REJUVENATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL VAGINAL REJUVENATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VAGINAL REJUVENATION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ENERGY BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ENERGY BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ENERGY BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL INTENSE PULSED LIGHT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL INTENSE PULSED LIGHT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL INTENSE PULSED LIGHT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LASER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LASER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL LASER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL RADIOFREQUENCY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RADIOFREQUENCY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RADIOFREQUENCY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SURGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SURGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SURGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL HYMENOPLASTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HYMENOPLASTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HYMENOPLASTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LABIAPLASTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LABIAPLASTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL LABIAPLASTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL VAGINOPLASTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL VAGINOPLASTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL VAGINOPLASTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PREMENOPAUSAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PREMENOPAUSAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PREMENOPAUSAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PERIMENOPAUSAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL PERIMENOPAUSAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PERIMENOPAUSAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL POSTMENOPAUSAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL POSTMENOPAUSAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL POSTMENOPAUSAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL 18 TO 34 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL 18 TO 34 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL 18 TO 34 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL 35 TO 44 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL 35 TO 44 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL 35 TO 44 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL 45 TO 54 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL 45 TO 54 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL 45 TO 54 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL 55 AND ABOVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL 55 AND ABOVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL 55 AND ABOVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL COMBINED REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL COMBINED REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL COMBINED REJUVENATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL EXTERNAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL EXTERNAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL EXTERNAL REJUVENATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL INTERNAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL INTERNAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL INTERNAL REJUVENATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL AESTHETIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL AESTHETIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL AESTHETIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SPA & WELLNESS CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SPA & WELLNESS CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SPA & WELLNESS CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 98. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 99. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 100. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 101. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 102. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 103. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 104. EUROPE VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 125. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 126. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 127. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 128. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 129. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 130. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. AFRICA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. NATO VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. NATO VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 144. NATO VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 145. NATO VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 146. NATO VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 147. NATO VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 148. NATO VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 149. NATO VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. NATO VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. G7 VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. G7 VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 153. G7 VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 154. G7 VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 155. G7 VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 156. G7 VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 157. G7 VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 158. G7 VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. G7 VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. BRICS VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. BRICS VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 162. BRICS VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 163. BRICS VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 164. BRICS VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 165. BRICS VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 166. BRICS VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 167. BRICS VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. BRICS VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 180. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 181. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 182. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 183. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 184. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 185. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. ASEAN VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. GCC VAGINAL REJUVENATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 188. GCC VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 189. GCC VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 190. GCC VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 191. GCC VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 192. GCC VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 193. GCC VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 194. GCC VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. GCC VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL VAGINAL REJUVENATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 197. CHINA VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 198. CHINA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 199. CHINA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 200. CHINA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 201. CHINA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 202. CHINA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 203. CHINA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 204. CHINA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. CHINA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. JAPAN VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 217. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 218. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 219. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 220. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 221. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 222. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. JAPAN VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. INDIA VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. INDIA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 226. INDIA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 227. INDIA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 228. INDIA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 229. INDIA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 230. INDIA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 231. INDIA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. INDIA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. GERMANY VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 234. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 235. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 236. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 237. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 238. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 239. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 240. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 241. GERMANY VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 248. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 252. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 253. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 254. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 255. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 256. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 257. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 258. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. AUSTRALIA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. FRANCE VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 262. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 263. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 264. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 265. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 266. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 267. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. FRANCE VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 271. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 272. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 273. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 274. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 275. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 276. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 277. SOUTH KOREA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. ITALY VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. ITALY VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 280. ITALY VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 281. ITALY VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 282. ITALY VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 283. ITALY VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 284. ITALY VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 285. ITALY VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. ITALY VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. CANADA VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. CANADA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 289. CANADA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 290. CANADA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 291. CANADA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 292. CANADA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 293. CANADA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 294. CANADA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 295. CANADA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 311. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 312. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 313. BRAZIL VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. MEXICO VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 316. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 317. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 318. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 319. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 320. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 321. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. MEXICO VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. SPAIN VAGINAL REJUVENATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 324. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 325. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 326. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY ENERGY BASED, 2017-2032 (USD MILLION)
TABLE 327. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY SURGICAL, 2017-2032 (USD MILLION)
TABLE 328. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY HORMONAL STATUS, 2017-2032 (USD MILLION)
TABLE 329. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 330. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 331. SPAIN VAGINAL REJUVENATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 332. GLOBAL VAGINAL REJUVENATION MARKET SHARE, BY KEY PLAYER, 2025
TABLE 333. GLOBAL VAGINAL REJUVENATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Alma Lasers Ltd.
  • Asclepion Laser Technologies GmbH
  • BTL Industries Ltd.
  • Candela Corporation
  • Cutera Inc.
  • Cynosure Inc.
  • DEKA M.E.L.A. S.r.l.
  • Eunsung Global Corp.
  • Fotona d.o.o.
  • Hironic Co., Ltd.
  • Hologic Inc.
  • InMode Ltd.
  • Jeisys Medical Inc.
  • Lasering S.r.l.
  • Lumenis Ltd.
  • Lutronic Corporation
  • MedArt Inc.
  • Sciton Inc.
  • Syneron Candela Corporation
  • ThermiGen LLC
  • Venus Concept Group, Inc.
  • Viveve Medical Inc.
  • Wontech Co., Ltd.
  • Zimmer MedizinSysteme GmbH

Table Information